Implementation challenges of 3-month once-weekly rifapentine and isoniazid TB-preventive treatment in India
Open Access
- 18 March 2026
- journal article
- Published by Oxford University Press (OUP) in International Health
- Vol. 18 (6) , 801-809
Abstract
Background: Implementing three months of once-weekly rifapentine and isoniazid (3HP) for tuberculosis preventive therapy among household contacts (HHCs) of bacteriologically confirmed pulmonary TB patients in India presents programmatic challenges requiring understanding from beneficiary and provider perspectives. Methods: From May 2023 to March 2024, nine focus group discussions were conducted across five rural and urban program settings: three with HHCs who received 3HP (n=28) and six with frontline healthcare providers (n=69) delivering the regimen within a multicentric implementation study. Descriptive thematic analysis explored experiences, perceptions, and implementation challenges. Results: Analysis of FGDs yielded four major themes: (i) perceptions and acceptance of 3HP; (ii) barriers to 3HP; (iii) advocacy and communication and social mobilization; and (iv) suggestions for improving 3HP. Participants appreciated the short, once-weekly regimen and family encouragement supporting adherence. However, reluctance to undergo testing without symptoms, fear of side effects, stigma, and access barriers limited uptake. Suggested solutions included transport support, mobile X-ray services, reminder tools, and family DOTS providers. Providers highlighted workforce shortages and the need for additional staff. Conclusion: Both groups emphasized tailored counselling, strengthened community awareness, and media advocacy to improve uptake, adherence, and program sustainability of 3HP implementation at scale nationwide.Keywords
Funding Information
- Indian Council of Medical Research
This publication has 30 references indexed in Scilit:
- Advancing tuberculosis elimination in India: A qualitative review of current strategies and areas for improvement in tuberculosis preventive treatmentIJID Regions, 2024
- Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic DiseasesJAMA, 2024
- The 3 HP regimen for tuberculosis preventive treatment: safety, dosage and related concerns during its large-scale implementation in countries like IndiaThe Lancet Regional Health - Southeast Asia, 2024
- Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series designInternational Journal of Infectious Diseases, 2022
- Effect of a phone reminder system on patient-centered tuberculosis treatment adherence among adults in Northwest Ethiopia: a randomised controlled trialBMJ Health & Care Informatics, 2021
- Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the NetherlandsDrug Safety, 2020
- Implementing upfront mobile digital chest x-ray for tuberculosis diagnosis in India—feasibility and benefitsTransactions of the Royal Society of Tropical Medicine and Hygiene, 2020
- Preventive therapy for latent tuberculosis infection—the promise and the challengesInternational Journal of Infectious Diseases, 2017
- Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected personsAIDS, 2016
- Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groupsInternational Journal for Quality in Health Care, 2007